We are live on
!
Find out more
TC
Tavio Capital Portfolio holdings
AUM
$75.4M
1-Year Est. Return
27.99%
This Fund
S&P 500
This Quarter
Est. Return
+18.54%
1 Year Est. Return
+27.99%
3 Year Est. Return
+81.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$75.4M
AUM Growth
+$6.15M
(+8.9%)
Cap. Flow
-$5.33M
Cap. Flow
% of AUM
-7.06%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
3
Increased
2
Reduced
3
Closed
1
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
+$6.6M |
| 2 |
Baxter International
BAX
|
+$5.96M |
| 3 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$3.55M |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$2.74M |
| 5 |
Cigna
CI
|
+$896K |
Top Sells
| 1 |
Centene
CNC
|
+$12.1M |
| 2 |
Molina Healthcare
MOH
|
+$9.43M |
| 3 |
McKesson
MCK
|
+$2.68M |
| 4 |
HCA Healthcare
HCA
|
+$820K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Molina Healthcare
MOH
$11.7B
| $16.3M | 21.58% |
91,479
-55,383
| -38% | -$9.43M |
|
|
2
McKesson
MCK
$98.6B
| $15.3M | 20.25% |
99,594
-18,533
| -16% | -$2.68M |
|
|
3
Zimmer Biomet
ZBH
$17.7B
| $15.3M | 20.22% |
131,654
+57,246
| +77% | +$6.6M |
|
|
4
Cigna
CI
$74.7B
| $14.1M | 18.69% |
75,163
+4,725
| +7% | +$896K |
|
|
5
Baxter International
BAX
$11.7B
| $5.89M | 7.81% |
+68,405
| New | +$5.96M |
|
|
PDCO
6
DELISTED
Patterson Companies, Inc.
PDCO
| $4.46M | 5.92% |
+202,943
| New | +$3.55M |
|
|
EXAS
7
DELISTED
Exact Sciences
EXAS
| $2.98M | 3.96% |
+34,329
| New | +$2.74M |
|
|
8
Centene
CNC
$32.7B
| $1.18M | 1.57% |
18,615
-186,597
| -91% | -$12.1M |
|
|
9
HCA Healthcare
HCA
$82.9B
| – | – |
-9,125
| Closed | -$820K |
|
Similar funds
PC
EGPO
AIS
MCMT
NBG
FC
SCM
MVM
Tavio Capital's Q2 2020 Portfolio in Review
As of Q2 2020, Tavio Capital held 9 positions worth $75.4M, up 8.9% from $69.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Tavio Capital withdrew a net $5.33M in Q2 2020, closing 1 position and reducing 3 holdings. Its most notable exit was HCA Healthcare, an estimated $820K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
Against the trend, Tavio Capital opened a new position in Baxter International worth $5.89M.
- Tavio Capital's largest Q2 2020 buy was Baxter International: 68,405 shares worth $5.89M.
- Tavio Capital added most to Zimmer Biomet in Q2 2020, an estimated $6.6M increase.
- Tavio Capital's biggest Q2 2020 reduction was Centene, cutting an estimated $12.1M.
- Tavio Capital fully exited HCA Healthcare in Q2 2020, selling an estimated $820K.
- Tavio Capital's ten largest holdings make up 100% of its $75.4M portfolio in Q2 2020.
- Tavio Capital opened 3 new positions and closed 1 in Q2 2020.
- Tavio Capital's portfolio value rose 8.9% quarter-over-quarter to $75.4M.
Based on Tavio Capital's 13F filing for Q2 2020, filed 13 Aug 2020.